Find a TenderAwardedContract details notice
Published 18 Jun 2025, 12:09 BST

Official UK procurement notice

715104450-Complusory Drug Testing Quality Assurance

Official notice

Authority: Ministry of Defence (Central government)

ServicesOpen procedureAbove thresholdSME suitableVCSE suitable
Sectors: Architecture & Engineering (71) Delivery: UK
Published estimate£190,000≈ £95k / year · £228,000 inc. VAT · 1 value update16.7% below published estimate
Submissions closed 11 Feb 2026awarded 31 Mar 2026
Awarded to Kings College London
Contract term 2 yrsends 31 Mar 2028 · up to 31 Mar 2031 with extensions · starts 1 Apr 2026

What is being bought

Published requirement description

The provision of Quality Assurance support to the Armed Forces Compulsory Drug Testing (CDT) programme.

responsibilities include:

a. conduct ‘blind performance testing’ of the Authority’s urinalysis contractor’s laboratory by providing and inserting quality assured control

samples, to replicate the collection of a sample from an individual;

b. perform on-site inspections of the urine analysis department of the Authority’s urinalysis contractor;

c. conduct an audit trail of samples pre-selected by the Authority;

d. be prepared to attend any review which may arise as a result of their work, and give independent advice and evidence as required by the

Authority;

e. notify the Authority of any additional and relevant legislation or guidelines to the programme as they occur;

f. review and validate any experimental work, research or study conducted by the Authority’s urinalysis contractor or by other third parties;

g. provide advice to the Authority on the technical and managerial merits of laboratories invited to tender for the re-let of the Authority’s

urinalysis contract;

h. submit an annual written report to the Authority, to include a laboratory inspection report and the scientific conduct of the programme during

the previous calendar year.

  • The authority expects to re-tender this requirement around 1 Nov 2027, 23:59 GMT.

CPV: Analysis services · Laboratory services

The lotProcurement structure

single lot · value published
Lot #1AwardedRenewal 2 yrsSMEVCSEPublished value£190,000
Contract period: 1 Apr 2026 – 31 Mar 2028 (2 yrs) · up to 31 Mar 2031 with extensionsValue: £190,000 exc. VAT · £228,000 inc. VAT
Delivery: UKEligibility: SME eligibleVCSE eligible
Extensions: 3x 1Year Option years
Pre-qualification & selection criteria (PQQ)1
  • Economic & financial standing

    See qualification envelope of the ITT on the DSP.

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
  • Technical: 60% 50% Technical 10% Social Value Please see DEFFORM 47 for further information
  • Price: 40% Price Please see DEFFORM47 for further information.
Conditions of participation1
  • Economic & financial standing

    See qualification envelope of the ITT on the DSP.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Services
Notice status
Awarded
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Yes · next expected 1 Nov 2027
First published
18 Jun 2025, 12:09 BST
Last source update
16 Jun 2026, 16:13 BST
Award evaluation window
Submission end – 6 Mar 2026
Authority reference
715104450
FTS notice number
2026/S 000-002101
Latest notice
Contract details notice (UK7)
Classification (CPV)
Analysis servicesLaboratory services
Delivery area
UK
Official registry OCID
ocds-h6vhtk-054ef7 Find a Tender
Contract terms summary

Payment in Arrears.

How it was run

Official notice
Run through: Defence Sourcing Portal · Who buys & how to bid on MOD DSP
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Free · registration requires an NCAGE code — obtain in advance · before you can bid: NCAGE
Submission deadline
11 Feb 2026, 10:00 GMT
Clarification deadline
19 Jan 2026, 10:00 GMT
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

Tenders to be submitted electronically via-

contracts.mod.uk/go/15329964019B9E9162F3 ↗

Timeline

18 Jun 2025 → 16 Jun 2026 · 11 dates
  1. Planning notice published
    18 Jun 2025, 12:09 BST
  2. Market engagement
    18 Jul 2025, 23:59 BST

    REQUEST FOR INFORMATION

    REFERENCE: 62085507 – The Provision of Quality Assurance to the Armed Forces Compulsory Drug Testing (AFCDT) Programme

    CUSTOMER: APSG, D Pers, Ministry of Defence (The Authority)

    ESTIMATED START DATE: Contract Start Date 01 April 2026

    DATE RESPONSE REQUIRED: 18 July 2025

    Dear Potential Provider,

    We would like to notify you of a potential upcoming requirement, and by doing so we are keen to understand where the market stands in terms of our requirement below.

    The Armed Forces Compulsory Drug Testing (CDT) mission is to minimise substance misuse in the Armed Forces through implementation of the policy of Prevention, Deterrence and Regulation, to reduce the deleterious effects of Substance Misuse (SM) on Operational Effectiveness, without causing excessive wastage.

    The current AFCDT is broken up into two contracts, the Urine Analysis (UA) AFCDT Contract and the AFCDT Quality Assurance Contract (QAC). This RFI only covers the AFCDT QAC requirements.

    The aim of the QAC is to conduct blind performance testing by providing and inserting quality control samples. This will then assist the Authority when dealing with any legal challenges made against a positive result.

    Please note the following general conditions:

    a. This RFI will help us to refine the requirement and conduct market research.

    b. We reserve the right not to proceed with this procurement. Nothing shall constitute a commitment to instigating a formal procurement process.

    c. Any and all costs associated with the production of such a response either to an RFI or any resultant competition must be borne by the Supplier. The Authority will not contribute in any way to meeting production costs of any response.

    d. Information contained within this document is confidential and must not be revealed to any third party without prior written consent from us.

    e. No down-selection of Potential Providers will take place as a consequence of any responses or interactions relating to this RFI.

    f. We expect that all responses to this RFI will be provided by Potential Providers in good faith to the best of their ability in the light of information available at the time of their response.

    g. No information provided by a Potential Provider in response to this RFI will be carried forward, used or acknowledged in any way for the purpose of evaluating the Potential Provider, in any subsequent formal procurement process that may take place.

    h. Should a Potential Provider fail to respond to this Supplier Questionnaire, it will not affect any further participation in any possible future procurement for this capability.

    OUR AIMS – WHAT WE WANT TO ACHIEVE

    The Customer is looking for one or more Suppliers to deliver the following aims:

    a. Monitor the collection procedures and make recommendations as appropriate.

    b. Advising on the AFCDT Standard Operating Procedures (SOP) for required updates.

    c. Attend days that an AFCDT team collects samples at a frequency agreed between the contractor and the Authority. QA visits to collection sites are normally carried out on a two monthly basis, although the actual rate may vary significantly depending upon specific issues or scientific problems.

    d. Review and advise on the training of CDTO, CA and Monitors.

    e. Submit a QA Site Inspection Report after conducting a visit to the Urine Analysis Contractors Lab.

    WHAT WE ARE LOOKING FOR

    The Customer is looking for Industry feedback on the following areas:

    1. There is an appetite for a singular provider to deliver all requirements detailed in the brief as a capability under a single contract, can this be achieved by your organisation?
    2. How would the potential provider seek to service the contract, which includes the provision of drug samples, IT infrastructure, communications and overall technical support throughout.
    3. Do any potential providers have the current capacity to deliver the capabilities? If a potential provider has a solution or is willing to develop a solution that fulfils the requirement, please provide a summary of the solution.
    4. If the potential provider does not have a current solution that meets the requirement in full, what level of investment would the potential provider envisage as a result, or would the potential provider seek to sub-contract capabilities, and how would this sub-contract capability be managed.
    5. Are there any major pit falls, issues or risks with the requirement?
    6. Where possible, are you able to provide a submission of a rough order of magnitude in regard to how much it would cost to fulfil this requirement in full, for 5 years.
    7. Where possible, confirm the lead time to establish a robust logistical plan for the delivery of quality control dug samples and other potential lead times to have a facility that provides the service up and running.
    8. If not, UKAS accredited, how long would it take for you to achieve this or similar accreditation required by the UK Government to conduct this requirement.
    9. How is your service currently measured by other customers of your services i.e. Key Performance Indicators.
    10. Are you able to provide examples of Key Performance Indicators?
    11. What are the most applicable social value missions and outcomes that be achieved in fulfilment of the requirement?

    (Please see assets.publishing.service.gov.uk/media/67ae1529e270ce… ↗)

    1. Are there any outcomes listed within the link above that provide a greater opportunity to provide social or economic benefit through delivery of the requirement? And if so, please provide justification.

    POTENTIAL PROVIDER QUESTIONS AND CLARIFICATIONS

    • Potential Providers may raise questions or seek clarification regarding any aspect of this RFI document at any time prior to the Clarification Period Closure. Questions must be submitted through to the multiuser [email protected]
    • To ensure that all Potential Providers have equal access to information regarding this Procurement, responses to questions raised by Potential Providers will be published in a questions and answers document, which will be available through the DSP.
    • Responses to questions will not identify the originator of the question.
    • If a Potential Provider wishes to ask a question or seek clarification without the question and answer being published in this way, then the Potential Provider must notify us and provide its justification for withholding the question and any response. If the Authority does not consider that there is sufficient justification for withholding the question and the corresponding response, the Potential Provider will be invited to decide whether:

    o the question/clarification and the response should in fact be published; or

    o It wishes to withdraw the question/clarification.

    INSTRUCTIONS FOR COMPLETION AND RETURN

    • Answers should be limited to a maximum of one side of A4 per question, using Ariel Font, Size 11.
    • Once completed please save as a PDF file and return to: [email protected]
    • Completed questionnaires should be returned by no later than 18 July 2025. Along with your completed responses you are invited to provide any marketing material/information that would help the MOD understand more about your organization and the market you operate in. Please note that failure to respond to this Supplier Questionnaire will not affect any further participation in any possible future procurement for this capability.
  3. Next notice expected
    25 Aug 2025, 23:59 BST
  4. Tender notice published278 days ago
    12 Jan 2026, 08:57 GMT
  5. Clarification questions by271 days ago
    19 Jan 2026, 10:00 GMT
  6. Submission deadline248 days ago
    11 Feb 2026, 10:00 GMT
  7. Award decision expected by224 days ago
    6 Mar 2026, 23:59 GMT
  8. Assessment summaries sent200 days ago
    31 Mar 2026, 00:00 BST
  9. Contract starts199 days ago
    1 Apr 2026, 00:00 BST
  10. Standstill ends186 days ago
    13 Apr 2026, 23:59 BST
  11. Latest notice published122 days ago
    16 Jun 2026, 16:13 BST

Notice history

12 events · 6 releases on Find a Tender · since 18 Jun 2025
  1. Preliminary market engagement notice published
    18 Jun 2025, 12:09 BST
    UK2
  2. Tender notice published
    12 Jan 2026, 08:57 GMT
    UK4
  3. Published value updated to £190,000
    12 Jan 2026, 08:57 GMT
    was £158,333
  4. Status changed to active
    12 Jan 2026, 08:57 GMT
  5. Procurement method changed
    12 Jan 2026, 08:57 GMT
  6. Deadline published: 11 Feb 2026, 10:00 GMT
    12 Jan 2026, 08:57 GMT
  7. Contract award notice published
    31 Mar 2026, 09:23 BST
    UK6
  8. Status changed to complete
    31 Mar 2026, 09:23 BST
  9. Contract award notice published
    31 Mar 2026, 10:05 BST
    UK6
  10. Contract signature expected
    16 Apr 2026, 23:59 BST
    scheduled
  11. Contract details notice published
    16 Jun 2026, 11:06 BST
    UK7
  12. Contract details notice published
    16 Jun 2026, 16:13 BST
    UK7
Routine re-releases (6)
  • 2026-03: 1 release · 31 Mar 2026
  • 2026-01: 1 release · 12 Jan 2026
  • 2025-06: 1 release · 18 Jun 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £158,3331 award exc. VAT
Bids received 1
Contracts signed 1latest 8 Jun 2026
Awarded toValueDateStatus
Kings College London16 Apr 2026 – 15 Apr 2028 · up to 15 Apr 2031Extensions: Option Years 3 x 1 year (12 Month) Option Years · Options: As above£158,33331 Mar 2026Awarded

Contracts

  • 715104450-Quality Assurance to the Armed Forces Compulsory Drug Testing (AFCDT) Programme- UK7 Notice · Kings College London

    Signed
    8 Jun 2026
    Value
    £158,333
    Period
    15 Jun 2026 – 14 Jun 2028 · up to 14 Jun 2031 with extensions
    Status
    active
    Extensions
    3 x 12 month Option Years
    Options
    3 x 12 month Option Years
    • Change The notiee has been amended to incude the contracting authorities email address and the redacted contract documents.

    No agreed KPIs: Not required

Bid statistics published by the authority

BidsSMEVCSEValid bid range
1final-stage tenders00—

Contracting authority & participating public bodies

Ministry of Defence

Contracting authorityPublic authority - central government GB-PPON: PHVX-4316-ZVGZ Marlborough Lines, Andover, South East, SP11 8HTContact name, email

Bidders & participating suppliers

1 commercial party on the notice
  • King's College LondonAwarded supplierGB-PPON: PHYJ-5565-GJZD Strand, London, London, WC2R 2LSContact email

Official documents & specifications (8)

Official links; attachments are not copied

Tender pack and attachments

  • Signed contract contractSigned contractPDF714890452 Statement of Requirement SC2 Schedule 2 Annex A
  • Signed contract contractSigned contractPDF714890452 SC2 Schedules

Notices published for this procedure